Antibody molecules and conjugates

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 12065496
APP PUB NO 20230183358A1
SERIAL NO

18053955

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to antibody molecules that bind epidermal growth factor receptor (EGFR) and/or c-Met and conjugates containing these antibody molecules. The antibody molecules and conjugates find application in the treatment of cancer, for example.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASTRAZENECA ABSE-151 85 SÖDERTÄLJE SWEDEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Buchanan, Andrew Grier Cambridge, GB 5 44
Comer, Frank Irvine Gaithersburg, US 3 0
Du, Qun Gaithersburg, US 19 61
Kasturirangan, Srinath Gaithersburg, US 20 74
Mazor, Yariv Gaithersburg, US 23 98
Yang, Chunning Gaithersburg, US 9 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 20, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 20, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 20, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00